• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
BPH
Click for more information
0.00% 1.2¢

BPH ENERGY LTD - Announcements

Market Cap $14.46M  ! watchlist Created with Sketch. Add to my watchlist

BPH Energy Limited is an Australia-based diversified company holding investments in... BPH Energy Limited is an Australia-based diversified company holding investments in resources and medical technology. The Company holds a significant interest in an unlisted oil and gas exploration company. The Company’s principal activities include investments in various companies, which include Clean Hydrogen Technologies Corporation (Clean Hydrogen Technologies), Cortical Dynamics Limited (Cortical), Advent Energy Limited, and Molecular Discovery Systems Limited (MDSystems). Clean Hydrogen Technologies is a USA Delaware registered company with technology to produce clean hydrogen. The Advent Energy Limited is an unlisted oil and gas exploration and production company based in Perth, Western Australia. The Cortical is a medical device company focused on developing brain function monitors by employing theories and technologies in the field. MDSystems focuses on drug discovery and the validation of biomarkers for disease, therapy and diagnostics.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
BPHBPH To Engage in Melanoma Drug Discovery ProgramPRICE SENSITIVE26/07/10
BPHCortical Dynamics Paper Published in Anesthesiology Journal23/07/10
BPH +PEP 11 Site Survey ReportPRICE SENSITIVE19/07/10
BPHResponse to ASX Price and Volume QueryPRICE SENSITIVE19/07/10
BPHAppendix 4C - quarterlyPRICE SENSITIVE12/07/10
BPHCortical Dynamics Australian Patent GrantedPRICE SENSITIVE09/07/10
BPH +Advent Energy - Additional Information to Earlier Release05/07/10
BPH +Advent Energy- Additional Information to Earlier Release05/07/10
BPH +Advent Energy - Additional Information to Earlier Release05/07/10
BPH +BPH Investee Advent Energy - Resource Estimate UpdatePRICE SENSITIVE05/07/10
BPHBecoming a substantial holder02/07/10
BPHHLS5 Operational UpdatePRICE SENSITIVE28/06/10
BPH +PEP 11 Drilling Preparation UpdatePRICE SENSITIVE17/06/10
BPHExpiry of Quoted Options - Updated Capital Structure15/06/10
BPHAppendix 3B28/05/10
BPHBPH Corporate Investee Advent Energy - Technical Update12/05/10
BPHCortical Dynamics Ltd Completes Functionality TrialPRICE SENSITIVE12/05/10
BPHBPH Corporate Ltd - 2010 BIO International Convention04/05/10
BPHCortical Dynamics Poster Presentation at ANZCA03/05/10
BPH +Advent Energy Contracts Drilling Rig for PEP11 Offshore NSW20/04/10
BPHAdvent Energy Contracts Drilling Rig for PEP11 Offshore NSWPRICE SENSITIVE20/04/10
BPH +Advent Energy Contracts Drilling Rig for PEP11 Offshore NSWPRICE SENSITIVE20/04/10
BPHTrading HaltPRICE SENSITIVE16/04/10
BPHAppendix 4C - quarterlyPRICE SENSITIVE14/04/10
BPHAdvent Energy Funding Update12/04/10
BPH +Advent Energy - Operations Update07/04/10
BPHAdvent Energy Limited Investment Update07/04/10
BPH +Advent Energy Limited Funding Update07/04/10
BPHNovel Anti-Microtubule Cancer Therapeutics UpdatePRICE SENSITIVE22/03/10
BPHBPH Presentation19/03/10
BPHResponse to ASX Price and Volume QueryPRICE SENSITIVE17/03/10
BPHAdvent Energy Site Survey17/03/10
BPHResults of Meeting10/03/10
BPHCortical Dynamics to Present to ANZCA02/03/10
BPH +MEC Development PEP 11 Drilling26/02/10
BPHAppendix 3B18/02/10
BPHHalf Yearly Report and AccountsPRICE SENSITIVE18/02/10
BPHNotice of General Meeting/Proxy Form09/02/10
BPH +Advent Energy Limited - PEP 11 Update01/02/10
BPHResults of Annual General Meeting15/01/10
BPHAppendix 4C - quarterlyPRICE SENSITIVE15/01/10
BPHAmended Appendix 3B08/01/10
BPHChange in substantial holding07/01/10
BPHAllocation of Placement Shares and Options/Top Twenty07/01/10
BPH +BPH Initiates Investment Option with Advent Energy06/01/10
BPHBPH Initiates Investment Option with Advent EnergyPRICE SENSITIVE06/01/10
BPHAllocation of Placement Shares and Options / Top 2029/12/09
BPHChange of Director's Interest Notice29/12/09
BPHChange of Director's Interest Notice29/12/09
BPH +Becoming a substantial holder from MMR29/12/09
BPHAppendix 3B29/12/09
BPHResults of Meeting29/12/09
BPHChange of Company Name29/12/09
BPHDisclosure Document22/12/09
BPHCortical Dynamics Successfully Completes NHMRC Grant15/12/09
BPHBioPharmica Limited Completes Capital Raising03/12/09
BPHAmended Indicative Timetable30/11/09
BPHBioPharmica General Meeting - Amended Indicative Timetable25/11/09
BPHNotice of Annual General Meeting/Proxy Form23/11/09
BPHNotice of General Meeting/Proxy Form23/11/09
BPHExtension of Time to Hold 2009 Annual General Meeting23/11/09
BPHHls5 Presentation 51st ASH Annual Meeting20/11/09
BPHNHMRC $608,500 Grant for HLS5PRICE SENSITIVE13/11/09
BPHBioPharmica Limited - 2009 Annual General Meeting Update10/11/09
BPHAppendix 4C - quarterlyPRICE SENSITIVE13/10/09
BPHAppendix 3B12/10/09
BPHMolecular Discovery Systems Spin Off and IPO02/10/09
BPHAnnual Report to shareholders30/09/09
BPHAppendix 3B29/09/09
BPHChange of Director's Interest Notice29/09/09
BPHSuccessful Completion of Shareholder Share Purchase Plan29/09/09
BPHExtension of Shareholder Share Purchase Plan21/09/09
BPHBPH Signs Option Deed with Advent EnergyPRICE SENSITIVE18/09/09
BPHShareholder Update - Advent Energy Limited16/09/09
BPHNew IPO Intended for BPH and Investment OverviewPRICE SENSITIVE15/09/09
BPHBPH Granted New Investment OpportunityPRICE SENSITIVE11/09/09
BPHTrading HaltPRICE SENSITIVE11/09/09
BPHInitial Director's Interest Notice31/08/09
BPHDirector Appointment31/08/09
BPHClarification of Grandbridge Investments26/08/09
BPHFinal Director's Interest Notice26/08/09
BPHResignation of Director26/08/09
BPHInvitation to Participate BioPharmica Share Purchase Plan24/08/09
BPHCleansing Statement Share Purchase Plan24/08/09
BPHBioPharmica - Promising results for Cortical DynamicsPRICE SENSITIVE20/08/09
BPHPreliminary Final Report and Audited Financial StatementsPRICE SENSITIVE19/08/09
BPHChange of Director's Interest Notice14/08/09
BPHBioPharmica Share Purchase Plan Indicative TimetablePRICE SENSITIVE12/08/09
BPHBioPharmica Shareholder Share Purchase Plan12/08/09
BPHUS Patent Granted for HLS5PRICE SENSITIVE11/08/09
BPHNew Anti-Mitotic Drug Development for Pre-Clinical TestingPRICE SENSITIVE10/08/09
BPHBPH Confirms 100% Ownership of New Anti Cancer AgentsPRICE SENSITIVE10/08/09
BPHAppendix 4C - quarterlyPRICE SENSITIVE13/07/09
BPHBPH Current Commercialisation Status Presentation01/07/09
BPHBPH Audio Webcast Link01/07/09
BPHCortical Dynamics - Project Update26/06/09
BPHMD Systems helping to find cure for Floppy Baby SyndromePRICE SENSITIVE02/06/09
BPHHLS5 Project Awarded Grant for Melanoma ResearchPRICE SENSITIVE26/05/09
BPHNZ Patent Granted for Cortical DynamicsPRICE SENSITIVE19/05/09
BPHResearch and Technology Farmin Agreement - BPH and UWAPRICE SENSITIVE06/05/09
BPHBPH To Engage in Melanoma Drug Discovery Program
26/07/10PRICE SENSITIVE
BPHCortical Dynamics Paper Published in Anesthesiology Journal
23/07/10
BPH +PEP 11 Site Survey Report
19/07/10PRICE SENSITIVE
BPHResponse to ASX Price and Volume Query
19/07/10PRICE SENSITIVE
BPHAppendix 4C - quarterly
12/07/10PRICE SENSITIVE
BPHCortical Dynamics Australian Patent Granted
09/07/10PRICE SENSITIVE
BPH +Advent Energy - Additional Information to Earlier Release
05/07/10
BPH +Advent Energy- Additional Information to Earlier Release
05/07/10
BPH +Advent Energy - Additional Information to Earlier Release
05/07/10
BPH +BPH Investee Advent Energy - Resource Estimate Update
05/07/10PRICE SENSITIVE
BPHBecoming a substantial holder
02/07/10
BPHHLS5 Operational Update
28/06/10PRICE SENSITIVE
BPH +PEP 11 Drilling Preparation Update
17/06/10PRICE SENSITIVE
BPHExpiry of Quoted Options - Updated Capital Structure
15/06/10
BPHAppendix 3B
28/05/10
BPHBPH Corporate Investee Advent Energy - Technical Update
12/05/10
BPHCortical Dynamics Ltd Completes Functionality Trial
12/05/10PRICE SENSITIVE
BPHBPH Corporate Ltd - 2010 BIO International Convention
04/05/10
BPHCortical Dynamics Poster Presentation at ANZCA
03/05/10
BPH +Advent Energy Contracts Drilling Rig for PEP11 Offshore NSW
20/04/10
BPHAdvent Energy Contracts Drilling Rig for PEP11 Offshore NSW
20/04/10PRICE SENSITIVE
BPH +Advent Energy Contracts Drilling Rig for PEP11 Offshore NSW
20/04/10PRICE SENSITIVE
BPHTrading Halt
16/04/10PRICE SENSITIVE
BPHAppendix 4C - quarterly
14/04/10PRICE SENSITIVE
BPHAdvent Energy Funding Update
12/04/10
BPH +Advent Energy - Operations Update
07/04/10
BPHAdvent Energy Limited Investment Update
07/04/10
BPH +Advent Energy Limited Funding Update
07/04/10
BPHNovel Anti-Microtubule Cancer Therapeutics Update
22/03/10PRICE SENSITIVE
BPHBPH Presentation
19/03/10
BPHResponse to ASX Price and Volume Query
17/03/10PRICE SENSITIVE
BPHAdvent Energy Site Survey
17/03/10
BPHResults of Meeting
10/03/10
BPHCortical Dynamics to Present to ANZCA
02/03/10
BPH +MEC Development PEP 11 Drilling
26/02/10
BPHAppendix 3B
18/02/10
BPHHalf Yearly Report and Accounts
18/02/10PRICE SENSITIVE
BPHNotice of General Meeting/Proxy Form
09/02/10
BPH +Advent Energy Limited - PEP 11 Update
01/02/10
BPHResults of Annual General Meeting
15/01/10
BPHAppendix 4C - quarterly
15/01/10PRICE SENSITIVE
BPHAmended Appendix 3B
08/01/10
BPHChange in substantial holding
07/01/10
BPHAllocation of Placement Shares and Options/Top Twenty
07/01/10
BPH +BPH Initiates Investment Option with Advent Energy
06/01/10
BPHBPH Initiates Investment Option with Advent Energy
06/01/10PRICE SENSITIVE
BPHAllocation of Placement Shares and Options / Top 20
29/12/09
BPHChange of Director's Interest Notice
29/12/09
BPHChange of Director's Interest Notice
29/12/09
BPH +Becoming a substantial holder from MMR
29/12/09
BPHAppendix 3B
29/12/09
BPHResults of Meeting
29/12/09
BPHChange of Company Name
29/12/09
BPHDisclosure Document
22/12/09
BPHCortical Dynamics Successfully Completes NHMRC Grant
15/12/09
BPHBioPharmica Limited Completes Capital Raising
03/12/09
BPHAmended Indicative Timetable
30/11/09
BPHBioPharmica General Meeting - Amended Indicative Timetable
25/11/09
BPHNotice of Annual General Meeting/Proxy Form
23/11/09
BPHNotice of General Meeting/Proxy Form
23/11/09
BPHExtension of Time to Hold 2009 Annual General Meeting
23/11/09
BPHHls5 Presentation 51st ASH Annual Meeting
20/11/09
BPHNHMRC $608,500 Grant for HLS5
13/11/09PRICE SENSITIVE
BPHBioPharmica Limited - 2009 Annual General Meeting Update
10/11/09
BPHAppendix 4C - quarterly
13/10/09PRICE SENSITIVE
BPHAppendix 3B
12/10/09
BPHMolecular Discovery Systems Spin Off and IPO
02/10/09
BPHAnnual Report to shareholders
30/09/09
BPHAppendix 3B
29/09/09
BPHChange of Director's Interest Notice
29/09/09
BPHSuccessful Completion of Shareholder Share Purchase Plan
29/09/09
BPHExtension of Shareholder Share Purchase Plan
21/09/09
BPHBPH Signs Option Deed with Advent Energy
18/09/09PRICE SENSITIVE
BPHShareholder Update - Advent Energy Limited
16/09/09
BPHNew IPO Intended for BPH and Investment Overview
15/09/09PRICE SENSITIVE
BPHBPH Granted New Investment Opportunity
11/09/09PRICE SENSITIVE
BPHTrading Halt
11/09/09PRICE SENSITIVE
BPHInitial Director's Interest Notice
31/08/09
BPHDirector Appointment
31/08/09
BPHClarification of Grandbridge Investments
26/08/09
BPHFinal Director's Interest Notice
26/08/09
BPHResignation of Director
26/08/09
BPHInvitation to Participate BioPharmica Share Purchase Plan
24/08/09
BPHCleansing Statement Share Purchase Plan
24/08/09
BPHBioPharmica - Promising results for Cortical Dynamics
20/08/09PRICE SENSITIVE
BPHPreliminary Final Report and Audited Financial Statements
19/08/09PRICE SENSITIVE
BPHChange of Director's Interest Notice
14/08/09
BPHBioPharmica Share Purchase Plan Indicative Timetable
12/08/09PRICE SENSITIVE
BPHBioPharmica Shareholder Share Purchase Plan
12/08/09
BPHUS Patent Granted for HLS5
11/08/09PRICE SENSITIVE
BPHNew Anti-Mitotic Drug Development for Pre-Clinical Testing
10/08/09PRICE SENSITIVE
BPHBPH Confirms 100% Ownership of New Anti Cancer Agents
10/08/09PRICE SENSITIVE
BPHAppendix 4C - quarterly
13/07/09PRICE SENSITIVE
BPHBPH Current Commercialisation Status Presentation
01/07/09
BPHBPH Audio Webcast Link
01/07/09
BPHCortical Dynamics - Project Update
26/06/09
BPHMD Systems helping to find cure for Floppy Baby Syndrome
02/06/09PRICE SENSITIVE
BPHHLS5 Project Awarded Grant for Melanoma Research
26/05/09PRICE SENSITIVE
BPHNZ Patent Granted for Cortical Dynamics
19/05/09PRICE SENSITIVE
BPHResearch and Technology Farmin Agreement - BPH and UWA
06/05/09PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
1.2¢ 		Change
0.000(0.00%) 		Mkt cap ! $14.46M
Open High Low Value Volume
1.2¢ 1.2¢ 1.2¢ $509 42.38K

Buyers (Bids)

No. Vol. Price($)
31 7125067 1.2¢
 

Sellers (Offers)

Price($) Vol. No.
1.3¢ 963554 2
View Market Depth
Last trade - 14.55pm 22/11/2024 (20 minute delay) ?
Last
1.2¢ 		  Change
0.000 ( 0.00 %)
Open High Low Volume
1.3¢ 1.3¢ 1.2¢ 388445
Last updated 15.55pm 22/11/2024 ?
BPH (ASX) Chart

Top Stories

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
Week 47 Wrap: HotCopper users' most watched; Brent lifts on Putin's scary letter; RFK dents CSL Welcome to the end of another week. Let's start with what HotCopper users have been watching and discussing.
Dale Gillham's weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse The $8.8 billion dollar merger between Sigma Healthcare and Chemist Warehouse is poised to reshape the Australian pharmacy landscape, consolidating power in the hands of two industry giants. But what does this mean for Australians @ greater access to cheaper medicines or the loss of small, commun...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.